Attention
This section of the web-site contains information on medicines, advertising of which is not foreseen by the legislation. Information in this section is intended for reference only, has exclusively scientific and informative character and should not be treated as advertising information for a wide range of people. According to the current legislation, access to this information is granted to medical and pharmaceutical employees. Please confirm that you are a medical or pharmaceutical employee.

Influcid®

Based on statistics, ARVI and influenza are the most common infections humanity suffers. Given the huge and growing variety of viruses that cause these diseases, you need a drug that can successfully cope with them.

Influcid®* is German natural combined medication that exerts antiviral effect not only on influenza viruses, but on most ARVI causing viruses.**

Yet, at the beginning of the disease Influcid facilitates rapid elimination of various manifestations of ARVI and flu, namely: headache, muscle aches, fever, rhinitis, pharyngitis. Influcid is a powerful natural interferon inducer, while interferon is an important element in the first line of bodily defense. Another Influcid advantage is its ability to significantly reduce the manifestations of asthenia (fatigue and weakness) after illness, which means that you’ll be able to return to normal life quite quickly.

Influcid® is a drug that not only actively fights viruses, eliminates ARVI and influenza symptoms, but also strengthens the immune system and protects against viruses. Hence, Influcid® can be used for both treatment and prevention of ARVI and influenza.

There are two types of Influcid® presentation i.e. tablets (adults and children starting from the 1st year of life) and drops (adults and children starting from 12) that are sold over the counter.

Influcid® – for immediate ARVI and influenza prevention and treatment

Influcid tablets: produced by DHU Arzneimittel GmbH & Co. KG (Germany), Marketing Authorization No. UA/6740/01/01;  30 ml Influcid solution: produced by  DHU Arzneimittel GmbH & Co. KG (Germany), Marketing Authorization No. UA/6740/02/01.

*Drug advertising. Read instructions carefully and consult a doctor before use. Keep out of the reach of children.

** M.Yu. Yeropkin et al. Name of the article/ “Russian Medical Journal”  Medical Review. – 2011. – No.18.

Self-medication can be harmful to your health

 

Prophylaxis and treatment of influenza and ARVI. Natural interferon inductor

Formulation: pills, No.  60, 3 blisters 20 pills each

Composition:
Aconitum Trit. D3 25 mg
Gelsemium Trit. D3 25 mg
Ipecacuanha Trit. D3 25 mg
Phosphorus Trit. D5 25 mg
Bryonia Trit. D2 25 mg
Eupatorium perfoliatum Trit. D1 25 mg

Other ingredients: Lactose monohydrate, magnesia stearate, wheat starch.

Formulation: Solution for oral administration, vial, 30 ml, No. 1

Composition:
Aconitum Dil. D3 10 g/100 g
Gelsemium Dil. D3 10 g/100 g
Ipecacuanha Dil. D3 10 g/100 g
Phosphorus Dil. D5 10 g/100 g
Bryonia Dil. D2 10 g/100 g
Eupatorium perfoliatum Dil. D1 10 g/100 g

Other ingredients: Eucalyptus globules (aromatic substance), 96% of ethanol, purified water.

Alcohol content: 45% (by volume).

Pharmacotherapeutic group: Complex homeopathic medication. ATC code: R05X.

Indications: Prophylaxis and treatment of influenza and ARVI.

Counterindications:
Since Influcid, in the solution formulation for oral intake, contains alcohol, it shall not be administered to patients with alcohol dependence. Hypersensitivity to medication components.

Adverse effects:
In very rare cases, hypersensitivity reactions are possible including skin rash, gastrointestinal disorders (such as nausea, vomiting, and diarrhea).
In case of any adverse reaction appearance, it is necessary to stop intaking the medication and consult a doctor.

Interactions: No interactions have been determined. According to clinical trial data, Influcid may be used successfully in complex therapy.

Overdosage: Overdosage may cause growth of adverse reaction rate.

Storage requirements: To be kept at up to 25°C.

Shelf life: 5 years.

Sell condition: over the counter.

Registered
In Germany Since 1928 Nisylen
In Ukraine since 1997 Influcid

Influcid is complex homeopathic medication. It contains 6 active components most acceptable for treatment of acute upper respiratory tract catarrhal diseases and influenza. It is an agent quickly suppressing typical symptoms of acute respiratory tract infection, such as fever, headache, muscle pain, along with rhinitis and pharyngitis. The medication enhances natural protection functions of an organism and promotes quick recovering after getting ill, thus preventing and reducing development of any exhaustion signs (asthenic syndrome). Use of the medication at the first manifestation of the disease or immediately after contacting ill persons promotes prevention of disease development.

Important:

  • Interferon induction activity of Influcid has been proved. The interferon induction activity of Influcid is comparable with that of Cycloferon.

F.I. Ershov. Reasonable Pharmacotherapy of Influenza and ARVI, “Pharm. Vestnik», 2003, No. 39

Antiviral Influcid activity as regards seasonal (H1N1, H3N2, and B) and pandemic A (H1N1) influenza has been proved.

It shows in vitro antiviral activity regarding a wide spectrum of ARVI viruses: adenoviruses, coronaviruses, respiratory syncytial virus, and parainfluenza virus)

M.Yu. Eroplin, V.A. Grigorieva. “Influcid Medication Activity in Model Systems”//MEDLINE-Express, 2007, No. 6, Page 23-26

  • On the background of Influcid administration, decrease of ARVI sickness rate, almost twice, is observed as compared with children having got no medicamentous prophylaxis.
  • Influcid efficacy index regarding influenza infection and other ARVI reaches 80 % allowing to classify the medication as high efficacy one as regards respiratory viruses**

T.I. Garashchenko, M.V. Garashchenko, M.V. Mezentseva

  • Clinical and Immunologic Grounding of Homeopathic Medications Regarding their Use for Influenza and ARVI Prophylaxis and Treatment // Russian Medicinal Journal.-2005.-T.13, No. 21.- Pages 1432-1437.

 Preventive use of Influcid for 1 month promotes decrease of rate, duration, and severity of ARVI for 3 months.

S.A. Mokkia-Serbina, Institute of Pediatry, Obstetrics, and Gynecology, No. 6,2009

Pills

In acute disease period:

For children aged 1 to 12 years: 1 pill every 2 h (but not exceeding 8 pills a day) till clinical enhancement, then 1 pill 3 times a day.

For children aged over 12 and adults, in acute disease period: 1 pill every hour (but not exceeding 12 pills a day) till clinical enhancement, then 1 or 2 pills 3 times a day. The treatment shall last 7 to 10 days.

For influenza and ARVI prophylaxis,

  • for children aged 1 to 12 years: 1 pill 3 times a day;
  • for children aged over 12 years and adults: 1 or 2 pills 3 times a day.

Duration of intaking after contacting persons ill with ARVI or influenza: 1 week.

The pills shall be intaken sublingually, 30 min. prior to or after taking food, by sucking them slowly in one’s mouth. For treatment of children aged up to 3 years, the pill may be dissolved in small amount of water (for example, in a tea spoon).

Solution for oral intake

In acute period of disease, children aged 12 and more years as well as adults shall intake 10 drops every hour (but not exceeding 12 times a day) till clinical enhancement, then 10 to 20 drops 3 times a day till complete recovery. Treatment duration: 7 to 10 days (till complete disappearing of symptoms).

For ARVI prophylaxis, children aged 12 and more years as well as adults shall intake 10 drops of the solution 3 times a day. Duration of intaking after contacting persons ill with ARVI or influenza: 1 week.

The solution shall be intaken 30 min. prior to or after taking food, holding it in one’s mouth before swallowing. For children aged over 12, the medication may be dissolved in small amount of water (for example, in a tea spoon).

Use of homeopathic medications may cause initial, temporary worsening. In such a case, the patient shall terminate the medication intake and consult a doctor.

Influcid, in the solution formulation for oral intake, contains 46% (by volume) of alcohol, thus there is high risk for patients suffering liver diseases or alcoholism, and also for pregnant women.

For children aged 1 to 12 years, it is recommended to administer Influcid in pills.

In case of high body temperature or its rise up to 39°C and higher, retaining or obscurity of symptoms, or else appearance of new ones, it is recommended to consult a doctor, because the state may be associated with diseases requiring medical help.

Warning for patients with gluten enteropathy. Pill formulation of Influcid contains wheat starch and lactose, so patients with rare hereditary forms of intolerance to galactose, lactase insufficiency, or syndrome of glucose-galactose malabsorption shall not use this medication.

Intaking in a period of pregnancy or lactation: Influcid may be intaken in a period of pregnancy or lactation only after thorough assessment, by a doctor, of the proportion: advantage for the mother/risk for the fetus (child).

Children: Influcid in solution formulation, for oral intake, is administrated for children aged over 12, while in pill formulation it is administered to children aged over 1 year.

Effecting  reaction rate when driving a vehicle or working with other mechanisms: No effect.

0

Ask a question